Article info

Effectiveness of nirmatrelvir-ritonavir versus azvudine for adult inpatients with severe or critical COVID-19

Authors

  • Huan Zhang Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of ChinaDepartment of Cardiac Vascular Surgery Critical Care Medicine, The Third People’s Hospital of Chengdu, Chengdu, People's Republic of China PubMed articlesGoogle scholar articles
  • Tan Xiaojiao Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China PubMed articlesGoogle scholar articles
  • Junjun Chen Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of ChinaDepartment of Critical Care Medicine, West China Tianfu Hospital of Sichuan University, Chengdu, People's Republic of China PubMed articlesGoogle scholar articles
  • Zheng Zhang Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China PubMed articlesGoogle scholar articles
  • Chenxi Wang Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China PubMed articlesGoogle scholar articles
  • Haiqing Shi Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China PubMed articlesGoogle scholar articles
  • Yao Li Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China PubMed articlesGoogle scholar articles
  • Jianbo Li Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China PubMed articlesGoogle scholar articles
  • Yan Kang Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of ChinaDepartment of Critical Care Medicine, West China Tianfu Hospital of Sichuan University, Chengdu, People's Republic of China PubMed articlesGoogle scholar articles
  • Xiaodong Jin Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China PubMed articlesGoogle scholar articles
  • Xuelian Liao Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of ChinaDepartment of Critical Care Medicine, West China Tianfu Hospital of Sichuan University, Chengdu, People's Republic of China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Xuelian Liao; liaoxuelian{at}scu.edu.cn; Mr Xiaodong Jin; zh_jxd{at}163.com
View Full Text

Citation

Zhang H, Xiaojiao T, Chen J, et al
Effectiveness of nirmatrelvir-ritonavir versus azvudine for adult inpatients with severe or critical COVID-19

Publication history

  • Received July 10, 2023
  • Accepted March 15, 2024
  • First published April 10, 2024.
Online issue publication 
April 10, 2024
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.